Results: According to FDR, seven immunophenotypes associated with GBM risk: CD33br HLA DR+ AC (FDR = 0.009), CD38 on PB/PC (FDR = 0.046), CD66b on CD66b++ myeloid cell (FDR = 0.019), CD3 on CD39+ resting Treg (FDR = 0.009), HVEM on CM CD8br (FDR = 0.050), CD45 on CD33br HLA DR+ CD14dim (FDR = 0.027), and CD86 on CD62L+ myeloid DC (FDR = 0.048). This evidence concerns the gene SELL and glioblastoma.